A major achievement with far-reaching implications for treating deadly skin cancer has been discovered by Tel Aviv University ...

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...

This review highlights the potential of natural polysaccharide microneedles in cancer immunotherapy, focusing on localized ...

The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...

With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...

-- Proceeds to drive global Phase 3 trial for ASP-1929, targeting BLA submission to the U.S. FDA in 2028 -- Financing led by international life science fund TaiAx, with participation from the largest ...

Happy New Year! 2025 was a year of exciting news in the life sciences field, and we’re sure 2026 will follow in its footsteps ...

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune ...

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...